DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash flow ...

Shares of Danaher Corp. DHR advanced 1.65% to $241.90 Thursday, on what proved to be an all-around dismal trading session for ...

Danaher Corp (DHR) stock saw a modest uptick, ending the day at $244.11 which represents a slight increase of $5.75 or 2.41% from the prior close of $238.36. The stock opened at $239.61 and touched a ...

Danaher Corp. closed 13.34% below its 52-week high of $281.70, which the company reached on August 1st.

Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Danaher Corp (DHR) stock saw a decline, ending the day at $238.36 which represents a decrease of $-3.54 or -1.46% from the prior close of $241.9. The stock opened at $242.17 and touched a low of $238.

Arkadios Wealth Advisors trimmed its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 6.1% in the 4th quarter, ...

LVW Advisors LLC trimmed its position in shares of Danaher Co. (NYSE:DHR – Free Report) by 28.6% in the 4th quarter, Holdings ...

Investors in Danaher Corp (Symbol: DHR) saw new options begin trading today, for the June 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay ...

Senator Elizabeth Warren has called on President-elect Trump's defense secretary pick, Pete Hegseth, to divest from thousands ...

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

Respiratory disease testing companies are Koninklijke Philips N.V., Niterra., Thermo Fisher Scientific, QIAGEN, Abbott, Danaher Corp, Siemens Healthineers, etc ...